China Regenerative Medicine International Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was HKD 76.89 million compared to HKD 84.67 million a year ago. Net income was HKD 8.33 million compared to HKD 3.5 million a year ago. Basic earnings per share from continuing operations was HKD 0.0292 compared to HKD 0.0122 a year ago. Basic earnings per share was HKD 0.0292 compared to HKD 0.0122 a year ago.
For the nine months, sales was HKD 163.14 million compared to HKD 199.98 million a year ago. Net income was HKD 10.56 million compared to HKD 19.73 million a year ago. Basic earnings per share from continuing operations was HKD 0.037 compared to HKD 0.1103 a year ago.